4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-24-039822
COO and SVP, Compliance sold 24,150 shares at $16.90 ($408,050)
- COO and SVP, Compliance acquired 24,150 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kestenberg-Messina Kaitlin M. · COO and SVP, Compliance
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-30 | Exercise or conversion : show line 1 in the form | +8,125 | $2.35 | $19,094 | 457,213 | D |
| 2024-08-30 | Exercise or conversion : show line 2 in the form | +4,375 | $2.59 | $11,331 | 461,588 | D |
| 2024-08-30 | Exercise or conversion : show line 3 in the form | +6,650 | $5.94 | $39,501 | 468,238 | D |
| 2024-08-30 | Exercise or conversion : show line 4 in the form | +5,000 | $4.72 | $23,600 | 473,238 | D |
| 2024-08-30 | Sale : show line 5 in the form | −24,150 | $16.90 | $408,050 | 449,088 | D |
| Open-market sales · 24,150 sh · avg $16.90 · $408,050 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-30 | Exercise or conversion : show line 6 in the form Common Stock | −8,125 | $2.35 | $19,094 | 3,750 | D |
| 2024-08-30 | Exercise or conversion : show line 7 in the form Common Stock | −4,375 | $2.59 | $11,331 | 0 | D |
| 2024-08-30 | Exercise or conversion : show line 8 in the form Common Stock | −6,650 | $5.94 | $39,501 | 0 | D |
| 2024-08-30 | Exercise or conversion : show line 9 in the form Common Stock | −5,000 | $4.72 | $23,600 | 0 | D |
Loading xslF345X05/form4.xml…